Results per Page:
Surveillance scrutinized: A critical look at screening for triple negative breast cancer recurrence
From the Parsons Lab, Clinical Research Division
Modelando el futuro de la prevención del VIH: ¿Puede una inyección aplicada dos veces al año potenciar el éxito de la PrEP?
Del Laboratorio Dimitrov, Departamento de Vacunas y Enfermedades Infecciosas
Prevention isn't enough: Invasive fusariosis affects cancer patients despite antifungal prophylaxis
From the Pergam Lab, Clinical Research and Vaccine Infectious Disease Divisions
Modeling the future of HIV prevention: Can a twice-yearly shot boost PrEP success?
From the Dimitrov Lab, Vaccine and Infectious Disease Division
At-home blood sampling passes the test for tracking pathogen exposure
From the Boeckh and Waghmare Labs, Vaccine and Infectious Disease Division
Matching tumors to treatments: An updated roadmap for head and neck squamous cell carcinoma
From the Gujral Lab, Human Biology Division
A tale of resistance: Losing USP22 lets small cell lung cancer rewrite its own SAGA
From the MacPherson Lab, Human Biology Division
A hidden vulnerability in pancreatic cancer opens the door to targeting an “undruggable” oncogene
From the Eisenman Lab, Basic Sciences Division
Primed and Ready: how blood stem cells keep genes on standby for rapid activation
From the Henikoff Lab, Basic Sciences Division
A new gene editing approach shields the immune system from HIV
From the Lieber Lab, University of Washington and the Cancer Consortium
Breast cancer survivors may benefit from a yearly blood test to detect new cancers
From the Etzioni Lab, Public Health Sciences Division and the Cancer Consortium
A new immune strategy to keep multiple myeloma at bay
From the Hill Lab, Translational Science and Therapeutics Division
Un triplete de fármacos prolonga la supervivencia sin progresión en el cáncer de mama avanzado
Del equipo de oncología mamaria del Departamento de Investigaciones Clínicas y el grupo de estudio VIKTORIA-1
Tumor suppressors gone rogue: a new class of targets for TCR-based cell therapies
From the Chapuis and Greenberg Labs, Translational Science and Therapeutics Division
A triplet of drugs extends progression-free survival in advanced breast cancer
From the Breast Oncology Team, Clinical Research Division, and the VIKTORIA-1 study group
A COVID-19 Antiviral, Reconsidered: What modeling reveals about Molnupiravir
From the Schiffer Lab, Vaccine and Infectious Disease Division
A promising new antibody treatment for a neglected respiratory virus
From the Boonyaratanakornkit Lab, Vaccine and Infectious Disease Division
Space Invaders: Extracellular bacterial occupation alters tumor fate
From the Bullman Lab, Human Biology Division
A new high-throughput method for flu vaccine strain selection
From the Bloom Lab, Basic Sciences Division
More than nutrition: How breast milk IgG trains infant immunity
From the Koch Lab, Basic Sciences Division